Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L37a pseudogene 8 (RPL37AP8) is one of several processed pseudogenes related to the functional ribosomal protein L37a gene (RPL37A). This pseudogene does not produce a functional protein and is not implicated in any known biological function, disease process, or pharmacologic mechanism. It is annotated as a probable non-coding region, lacking evidence for translation or drug targeting and has no known role as a therapeutic target[3][6][12][14]. RPL37AP8 is a pseudogene and not a functional gene or therapeutic target. It is not considered a receptor, enzyme, transporter, or any other canonical drug target class[3][14]. There are no known drugs, disease roles, biomarkers, or safety issues associated with this pseudogene[3][12][14]. The true protein-coding gene is RPL37A (Ribosomal protein L37a), which is a structural constituent of the ribosome and associated with protein synthesis, but RPL37AP8 specifically is a nonfunctional pseudogene[1][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L37a pseudogene 8 (RPL37AP8).